H7N9 Bird Flu Virus - Biotech, Pharma and Life Science Channel

19:53 EDT 24th October 2014 | BioPortfolio

Avian influenza A H7 viruses are a group of influenza viruses that normally circulate among birds. The avian influenza A(H7N9) virus is one subgroup among the larger group of H7 viruses. Although some H7 viruses (H7N2, H7N3 and H7N7) have occasionally been found to infect humans, no human infections with H7N9 viruses have been reported until recent reports from China.

News Articles [10 Associated News Articles listed on BioPortfolio]

Influenza A Infections - Pipeline Review, H2 2014

Recently added to the BioPortfolio report store, Influenza A Infections - Pipeline Review, H2 2014 is a new report from Global Markets Direct published on 2014-09-29. This 141-page report is availabl...

Novavax' H7N9 Avian Influenza VLP Vaccine Candidate With Matrix-M(TM) Delivers Positive Phase 1/2 Clinical Data

Vaccine and adjuvant were well-tolerated, consistent with the company's prior studies with saponin-based adjuvants Hemagglutination-inhibiting antibody responses similar to prior Novavax ...

New York Blood Center's Laboratory of Viral Immunology Gets Support for Developing Vaccines and Therapeutics Against Emerging Viruses

NEW YORK, Sept. 18, 2014 /PRNewswire-USNewswire/ -- NYBC's Laboratory of Viral Immunology has received a National Institutes of Health (NIH) grant to develop a mucosal universal influenza vaccine....

Hemispherx' Drug Ampligen Plus Intranasal Seasonal Influenza Vaccine Induces Cross-Reactive Antibody Formation Against Avian H5N1 and H7N9 Influenza HA in Humans

PHILADELPHIA, Sept. 15, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced today a peer-reviewed publication entitled "Intranasal Seasonal I...

InDevR Wins Barda Contract for Cutting-Edge Influenza Diagnostic

BOULDER, CO--(Marketwired - September 15, 2014) - InDevR, a Boulder-based life science company, announced today that it has signed a contract (HHSO100201400010C) with the Biomedical Advanced Research ...

Ansun BioPharma Announces Late Breaker Oral Presentation at ICAAC on the Clinical Activity of ParaDase™, an Investigational Drug for the Treatment of Severe Parainfluenza Infection

Ansun BioPharma announced today a late breaker oral presentation titled “DAS181 for the Treatment of Parainfluenza Virus Infections in 16 Hematopoietic Stem Cell Transplant Reci...

Avian influenza virus isolated in harbor seals poses a threat to humans

MEMPHIS, Tenn., Sept. 4, 2014 /PRNewswire-USNewswire/ -- A study led by St. Jude Children's Research Hospital scientists found the avian influenza A H3N8 virus that killed harbor seals along the New E...

Pandemic Influenza - Pipeline Review, H2 2014

Recently added to the BioPortfolio report store, Pandemic Influenza - Pipeline Review, H2 2014 is a new report from Global Markets Direct published on 2014-07-30. This 146-page report is available in...

NAS911 Being Evaluated as Co-Therapeutic for Treatment of Influenza

SCOTTSDALE, AZ -- (Marketwired) -- 08/06/14 -- New Amsterdam Sciences (NAS), an emerging bioscience company focused on treating respiratory illnesses, announced today the completion of initial confir...

InDevR Awarded $2.9 M to Advance Titer on Chip(R) for Pandemic Flu Vaccines

BOULDER, CO--(Marketwired - July 22, 2014) - InDevR, a Boulder-based life science company, announced today that it has received an SBIR Phase II grant from the National Institute of Allergy and Infect...

Events [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Ansun BioPharma

Ansun BioPharma is a clinical stage biopharmaceutical company focused on the development of unique host-directed anti-viral therapies for respiratory viruses. Ansun BioPharma has ...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine

A phase I prospective, randomized study in healthy adult subjects at a single center. Adult subjects age 18 to 47 years and meeting all enrollment criteria will choose to participate as s...

PubMed Articles [61 Associated PubMed Articles listed on BioPortfolio]

Human Influenza A(H7N9) Virus Infection Associated with Poultry Farm, Northeastern China.

We report on a case of human infection with influenza A(H7N9) virus in Jilin Province in northeastern China. This case was associated with a poultry farm rather than a live bird market, which may poin...

Poultry Market Closures and Human Infection with Influenza A(H7N9) Virus, China, 2013-14.

Closure of live poultry markets was implemented in areas affected by the influenza virus A(H7N9) outbreak in China during winter, 2013-14. Our analysis showed that closing live poultry markets in the ...

Serological Responses to an Avian Influenza A/H7N9 Vaccine Mixed at the Point-of-Use With MF59 Adjuvant: A Randomized Clinical Trial.

Human infections with avian influenza A/H7N9 have resulted in high morbidity and mortality in China.

Evaluation of avian influenza virus isolated from ducks as a potential live vaccine candidate against novel H7N9 viruses.

Recent outbreaks of a novel H7N9 avian influenza virus in humans in China raise pandemic concerns and underscore an urgent need to develop effective vaccines. Theoretically, live influenza vaccines ar...

Ultrasensitive electrochemical detection of avian influenza A (H7N9) virus DNA based on isothermal exponential amplification coupled with hybridization chain reaction of DNAzyme nanowires.

In this work, a simple and label-free electrochemical biosensor with duel amplification strategy was developed for DNA detection based on isothermal exponential amplification (EXPAR) coupled with hybr...

Novel Influenza A(H7N2) Virus in Chickens, Jilin Province, China, 2014.

In February 2014, while investigating the source of a human infection with influenza A(H7N9) virus in northern China, we isolated subtypes H7N2 and H9N2 viruses from chickens on the patient's farm. Se...

Avian Influenza A H7N9 Virus Induces Severe Pneumonia in Mice without Prior Adaptation and Responds to a Combination of Zanamivir and COX-2 Inhibitor.

Human infection caused by the avian influenza A H7N9 virus has a case-fatality rate of over 30%. Systematic study of the pathogenesis of avian H7N9 isolate and effective therapeutic strategies are nee...

Identification, Synthesis, and Evaluation of New Neuraminidase Inhibitors.

High-throughput screening was performed on ∼6800 compounds to identify KR-72039 as an inhibitor of H1N1 and H5N1 neuraminidases (NAs). Structure-activity relationship studies led to 3e, which inhibi...

Entry Properties and Entry Inhibitors of a Human H7N9 Influenza Virus.

The recently identified human infections with a novel avian influenza H7N9 virus in China raise important questions regarding possible risk to humans. However, the entry properties and tropism of this...

Detection of Avian Influenza A(H7N9) Virus from Live Poultry Markets in Guangzhou, China: A Surveillance Report.

A virologic surveillance program for A(H7N9) virus was conducted from April 15, 2013 to February 14, 2014 in Guangzhou, aiming to clarify the geographical distribution of A(H7N9) viruses among live po...

Medical and Biotech [MESH] Definitions

None available.

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

Public Health
Latest News Clinical Trials Research Drugs Reports Corporate
Public health is the scientific, political and sociological approach by a society to maximise the health of the population through disease preventaion and mainenance of healthy life-styles. The mains areas of public health are epidemiology, biostatistics...

Advertisement
review and buy H7N9 Bird Flu Virus market research data and corporate reports here

Channels Quicklinks